Coronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630)

K262412 · Barco NV · PGY · Oct 2, 2026 · Radiology

Device Facts

Record IDK262412
Device NameCoronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630)
ApplicantBarco NV
Product CodePGY · Radiology
Decision DateOct 2, 2026
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 892.2050
Device ClassClass 2

Indications for Use

The display is intended to be used for displaying and viewing digital images (excluding digital mammography) for review and analysis by trained medical practitioners.

Device Story

High-resolution LCD medical monitors (Coronis Fusion 4MP/6MP) for general radiology; used in clinical settings or home offices. Inputs: digital image data via DisplayPort or USB-C from PACS workstation. Operation: displays images with high luminance, uniformity, and stability; includes 'Intuitive Workflow Tools' (SpotView for region-of-interest enhancement/magnification/inversion; AAM for luminance/color space management per application). Features: integrated camera, microphones, speakers, ambient light/presence/temperature sensors. Output: visual representation of medical images for radiologist review. Benefits: consistent brightness, DICOM compliance, ergonomic reading, and workflow efficiency. Operated by radiologists/medical practitioners to facilitate diagnosis.

Clinical Evidence

No clinical or animal testing performed. Substantial equivalence supported by bench testing including MTF, pixel defects, temporal response, luminance metrics (max/min, uniformity, response, angular dependency), reflection coefficients, veiling glare, and color tracking. Compliance with EMC, safety, and environmental standards verified.

Technological Characteristics

High-resolution LCD monitors. Connectivity: 2x DisplayPort input, 1x DisplayPort output (future firmware), 1x USB-C (power/video/data), 2x USB-B 3.2, 2x USB-A 3.2, RJ-45 Ethernet. Sensors: Front, ambient light, internal temperature, presence. Multimedia: Camera, mic, speakers. Software: Optional QAWeb Enterprise (calibration) and Intuitive Workflow Tools (SpotView, AAM).

Indications for Use

Indicated for trained medical practitioners to display and view digital images (excluding digital mammography) for review and analysis.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

Reference Devices

Submission Summary (Full Text)

{1} FDA U.S. FOOD & DRUG ADMINISTRATION October 2, 2026 Barco NV Lieven De Wandel Regulatory Officer President Kennedypark 35 Kortrijk, 8500 Belgium Re: K262412 Trade/Device Name: Coronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630) Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: PGY Dated: September 3, 2026 Received: September 3, 2026 Dear Lieven De Wandel: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} K262412 - Lieven De Wandel Page 2 Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the {3} K262412 - Lieven De Wandel Page 3 Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Jessica Lamb, Ph.D., Assistant Director Imaging Software Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {4} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K262412 | ? | | Please provide the device trade name(s). | | ? | | Coronis Fusion 4MP (MDCC-4630) Coronis Fusion 6MP (MDCC-6630) | | | | Please provide your Indications for Use below. | | ? | | The display is intended to be used for displaying and viewing digital images (excluding digital mammography) for review and analysis by trained medical practitioners. | | | | Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | | Please select the age group(s) for which the device(s) is to be used. | ☐ Neonates/Newborns (Birth to < 29 days old) ☐ Infants (29 days old to < 2 years old) ☐ Children (2 years old to < 12 years old) ☐ Adolescents (12 years old to < 22 years old) ☐ Adults (22 years old and greater) | ? | {5} 510(k) #: K262412 510(k) Summary Prepared on: 2026-09-03 # Contact Details 21 CFR 807.92(a)(1) | Applicant Name | Barco NV | | --- | --- | | Applicant Address | President Kennedypark 35 Kortrijk 8500 Belgium | | Applicant Contact Telephone | +3256233211 | | Applicant Contact | Mr. Lieven De Wandel | | Applicant Contact Email | lieven.dewandel@barco.com | # Device Name 21 CFR 807.92(a)(2) | Device Trade Name | Coronis Fusion 4MP (MDCC-4630); Coronis Fusion 6MP (MDCC-6630) | | --- | --- | | Common Name | Medical image management and processing system | | Classification Name | Display, Diagnostic Radiology | | Regulation Number | 892.2050 | | Product Code(s) | PGY | # Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) | Predicate # | Predicate Trade Name (Primary Predicate is listed first) | Product Code | | --- | --- | --- | | K191845 | Coronis Fusion 4MP (MDCC-4430) | PGY | | K191845 | Coronis Fusion 6MP (MDCC-6530) | PGY | # Device Description Summary 21 CFR 807.92(a)(4) The Coronis Fusion 4MP (MDCC-4630) and Coronis Fusion 6MP (MDCC-6630) are medical computer displays designed for general radiology applications. The devices can also be used for home reading in radiology (physician's private practice or home office). The displays are high-resolution LCD monitors with improved technical characteristics that are important for accurate medical image review: high luminance, good luminance uniformity, good luminance ratio and luminance stability. The medical displays comes with special image-enhancing technologies to ensure consistent brightness over the lifetime of the display, noise-free images (=good luminance uniformity), ergonomic reading and automated compliance with DICOM and other medical image quality standards and guidelines. These technologies help the radiologist to make a swift and accurate diagnosis. Available video inputs/outputs: 2x DisplayPort input, 1 DisplayPort output, 1x USB-C. Note: At the moment of the planned release of the device the DP output functionality will not yet be available. It will become available with a future firmware upgrade. USB interfaces: 2x USB-B 3.2 upstream, 1x USB-C 3.2 upstream, 2x USB-A 3.2 downstream Ethernet port: RJ-45 connector as pass-through Ethernet port Multimedia features: Camera, microphones, speakers Sensors: Front sensor, Ambient Light Sensor, internal temperature sensors, presence sensor The displays can be used optionally with the downloadable QAWeb Enterprise software, listed under D332294 as a class 1 device with product code LHO. QAWeb Enterprise is a calibration software that is intended as a quality assurance software for the displays. QAWeb Enterprise software helps to keep the display DICOM compliant. {6} The displays can be used optionally with the downloadable Intuitive Workflow Tools, cleared in K191845 as a class 2 device with product code PGY. The Intuitive Workflow Tools are accessories for image enhancement on diagnostic displays: - SpotView: The Barco SpotView display feature allows focusing on a region of interest in an image by boosting the display's backlight such that the maximum luminance in provided inside the region of interest. SpotView also enables focused observation during reading by dimming images outside the region of interest and increasing the contrast in this region. Also magnification and inversion of pixels are possible with SpotView. - AAM – Application Appearance Manager: This workflow tool allows you to set the luminance as well as the color space for each application that is on the workstation. There are often multiple windows open on a screen, but not all of them need the high brightness of the diagnostic applications. These applications are addressed by the general term 'Intuitive Workflow Tools'. The integration of the Intuitive Workflow Tools with the displays have been de-risked, verified and validated to ensure that they do not affect the safety and effectiveness of the displays. The displays can be used with or without the Barco display controller boards. The display controller board is installed in a PACS workstation computer, connected to the display. ## Intended Use/Indications for Use 21 CFR 807.92(a)(5) The display is intended to be used for displaying and viewing digital images (excluding digital mammography) for review and analysis by trained medical practitioners. ## Indications for Use Comparison 21 CFR 807.92(a)(5) The indications for use are the same ## Technological Comparison 21 CFR 807.92(a)(6) The differences between the new and predicate devices are: - New multimedia board and software - Multi-media features – webcam, microphone and speakers - Proximity sensor is added - USB-C support is added (enabling power delivery, video, and data transfer) - Ethernet connectivity via RJ45 connection is added - New power supply Apart from these differences the new devices have the same technological characteristics as the predicate devices. ## Non-Clinical and/or Clinical Tests Summary & Conclusions 21 CFR 807.92(b) The below performance bench tests are performed and corresponding results reported for the modified device in comparison to the already cleared device as per the Physical Laboratory Testing instructions in "Guidance for Industry and FDA Staff: Display Devices for Diagnostic Radiology", issued in 2022: - Spatial resolution – MTF - Pixel defects, Artifacts - Temporal Response - Maximum and Minimum Luminance - Luminance response, Conformance to DICOM GSDF - Angular Dependency of Luminance - Luminance uniformity - Reflection coefficient – Display Reflectance incl. Specular, Diffuse & Haze coefficients - Veiling glare or small-spot contrast - Color tracking The tests showed that the MDCC-6630 has similar characteristics compared to already cleared device MDCC-6530 and did not reveal new issues of safety and performance. Additionally, the MDCC-6630 is compliant to EMC and Safety standards, the environmental tests (climate, mechanical and packed) and software tests passed. No animal testing or clinical testing has been performed. {7} As a conclusion we can state that the device MDCC-6630 is found to be substantially equivalent to the predicate device MDCC-6530, because: - The indications for use are the same as the predicate device - The technological characteristics discussed above do not raise questions of safety and effectiveness - The bench tests show that the display characteristics are equivalent to those of the predicate device
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...